Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study

BACKGROUND: Chronic hepatitis C virus (HCV) genotype (GT) 3 infection with advanced liver disease has emerged as a challenging to treat by direct-acting antivirals (DAAs), but the efficacy of DAAs in Chinese HCV-GT3 patients is rarely reported. This study aimed to analyze the efficacy of sofosbuvir...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Ya-Chao, Deng, Rong, Wang, Meng-Lan, Lv, Duo-Duo, Yuan, Man, Wang, Yong-Hong, Chen, En-Qiang, Tang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167801/
https://www.ncbi.nlm.nih.gov/pubmed/30285800
http://dx.doi.org/10.1186/s12985-018-1066-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167801/
https://www.ncbi.nlm.nih.gov/pubmed/30285800
http://dx.doi.org/10.1186/s12985-018-1066-8

Ejemplares similares